Vuong Trieu

5.1k citations
92 papers · 4.1k indexed · 2 hit papers · h-index 23
Topics
Cancer Treatment and Pharmacology (28 papers)Lipoproteins and Cardiovascular Health (12 papers)Cancer, Hypoxia, and Metabolism (12 papers)
Partner nations
United StatesItalyRussia

In The Last Decade

Vuong Trieu

82 papers receiving 4.0k citations

Hit Papers

Increased antitumor activity, intratumor paclitaxel conce...200620262012201920062011250500750

Peers

Vuong Trieu
Comparison fields: 5 of 111
  • Oncology 2.0k
  • Molecular Biology 1.2k
  • Biomaterials 969
  • Cancer Research 889
  • Surgery 607
Replace Andreas Wicki with:
Andreas Wicki Switzerland
Fumiaki Koizumi Japan
Paul Bhar United States
Àngels Fabra Spain
Hua Guo China
Barbara Haley United States
Paul M.J. McSheehy Switzerland
Arthur C. Louie United States
Deliang Fu China
Jun Qian China
Vuong Trieu relative to Andreas Wicki Switzerland Andreas Wicki's profile →
Citations per field
00.5×1.5×2.0×
Andreas Wicki · 1×
Citations per year

Countries citing papers authored by Vuong Trieu

Since Specialization
Citations

This map shows the geographic impact of Vuong Trieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vuong Trieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vuong Trieu more than expected).

Fields of papers citing papers by Vuong Trieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vuong Trieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vuong Trieu. The network helps show where Vuong Trieu may publish in the future.

Co-authorship network of co-authors of Vuong Trieu

This figure shows the co-authorship network connecting the top 25 collaborators of Vuong Trieu. A scholar is included among the top collaborators of Vuong Trieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vuong Trieu. Vuong Trieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 6
5 0
6 1
7 26
8 30
9 21
10 4
11 2
12 1
13
Pharmacokinetic and ADME study of nanoparticle albumin-bound 17AAG (nab-17AAG) in mice
2
14
Toxicology and safety pharmacology of nanoparticle albumin-bound (nab) rapamycin (ABI-009)
1
15
Characterization and in vitro/in vivo dissolution of nab-paclitaxel nanoparticles
7
16
SPARC overexpression enhances sensitivity to nab-paclitaxel in vivo
4
17
Nanoparticle albumin-bound (nab) rapamycin as an anticancer agent
5
18
Investigation of chemotherapy-induced tumor angiogenesis: Rationale for combination of nab-paclitaxel with anti-VEGF therapy
1
19 9
20 18

About Vuong Trieu

Vuong Trieu is a scholar working on Cancer Research, Oncology and Genetics, having authored 92 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (28 papers), Lipoproteins and Cardiovascular Health (12 papers) and Cancer, Hypoxia, and Metabolism (12 papers). The work is most often cited by research in Biomaterials (969 citations), Oncology (2.0k citations) and Cancer Research (889 citations). Vuong Trieu has collaborated with scholars based in United States, Italy and Russia. Frequent co-authors include Neil Desai, Patrick Soon‐Shiong, Fatih M. Uckun, Michael Hawkins, Tapas De, Andrew Yang, Walter J. McConathy, B Damascelli, Daniel D. Von Hoff and Leslie Louie. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026